Home > The T11 takes on the challenges of label production for clinical trial labels
In part 1 of this 2-part series, we discussed some of the challenges involved in producing labels for use in clinical trials — many of which can contribute to costly delays and other issues that affect clinical trial outcomes. In this blog, we look at one of the solutions that can overcome these challenges and help reduce errors, equipment expenses, and overall costs —The T11 Manual Mark & Verify, one of the solutions in Systech’s PCE Track and Trace line.
The T11 Manual Mark & Verify is an integrated solution for printing and visually inspecting labels. Its inherent flexibility makes it well suited for producing labels for investigational medicinal products (IMPs) used in clinical trials. Its benefits include:
Setting up label takes only minutes. Once the approved IMP label design and content are provided, the information is input manually or via software that links the company’s data source to the T11. The data is then dynamically assigned to a PDF template to create a label proof.
As labels are printed, they are visually inspected by the T11’s integrated camera. Two options are available to provide optimal verification of label information — a smart camera or a high-resolution camera.
Both camera types can conduct three types of verification: presence check, quality check and reference check. The choice of camera depends on label size, print resolution, and whether inspection is required for all components of the label or just a couple of them.
The label content is compared against the approved PDF. If any errors or omissions are found, the operator is immediately notified, and the production process stops. Verification of the faulty label’s removed is required before the system will continue production. This helps ensure that erroneous labels do not get used.
When the T11 is used with Systech’s PCE Line Manager track and trace software, additional capabilities are available. Among them: reporting on the origin of label errors so they can be mitigated.
Any organization involved in running clinical trials can benefit from using the T11. Its features are particularly beneficial for cost-sensitive emerging companies and startups, as well as companies running clinical trials in multiple countries and sites.
The best way to see how the T11 can benefit your organization is to see it in action. Schedule a free, no obligation on-site demo today.